{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:38:26Z","timestamp":1777045106594,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["SAF2012-36400"],"award-info":[{"award-number":["SAF2012-36400"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["SAF2016-80305-P"],"award-info":[{"award-number":["SAF2016-80305-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD12\/0042\/0022"],"award-info":[{"award-number":["RD12\/0042\/0022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD12\/0042\/0024"],"award-info":[{"award-number":["RD12\/0042\/0024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CB16\/11\/00286"],"award-info":[{"award-number":["CB16\/11\/00286"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CB16\/11\/00264"],"award-info":[{"award-number":["CB16\/11\/00264"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI13\/01488"],"award-info":[{"award-number":["PI13\/01488"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER)","award":["B2017\/BMD-3637"],"award-info":[{"award-number":["B2017\/BMD-3637"]}]},{"name":"Ram\u00f3n y Cajal Program","award":["RYC-2013-12880"],"award-info":[{"award-number":["RYC-2013-12880"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.phrs.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T13:10:43Z","timestamp":1515157843000},"page":"236-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Regulator of calcineurin 1 modulates vascular contractility and stiffness through the upregulation of COX-2-derived prostanoids"],"prefix":"10.1016","volume":"133","author":[{"given":"Ana B.","family":"Garc\u00eda-Redondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Briones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda S.","family":"D\u00edaz del Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Gonz\u00e1lez-Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"M\u00e9ndez-Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel R.","family":"Campanero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Salaices","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.01.001_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.HYP.35.1.68","article-title":"Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells","volume":"35","author":"Ohnaka","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.001_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.106.115287","article-title":"Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats","volume":"321","author":"\u00c1lvarez","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2018.01.001_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jash.2007.01.005","article-title":"Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats","volume":"1","author":"Montezano","year":"2007","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.001_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/HJH.0b013e32834f043b","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress","volume":"30","author":"Mart\u00edn","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.001_bib0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","article-title":"Endothelium-mediated control of vascular tone: COX-1 and COX-2 products","volume":"164","author":"F\u00e9l\u00e9tou","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20120651","article-title":"New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension","volume":"126","author":"Hernanz","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2018.01.001_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.prostaglandins.2017.03.003","article-title":"Prostanoids in the pathophysiology of human coronary artery","volume":"133","author":"Ozen","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.phrs.2018.01.001_bib0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/01.hjh.0000166844.42227.5c","article-title":"Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt induced hypertension","volume":"23","author":"Adeagbo","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.001_bib0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.hjh.0000163145.12707.63","article-title":"Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses","volume":"23","author":"\u00c1lvarez","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.001_bib0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.109.132258","article-title":"Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids","volume":"53","author":"Virdis","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.001_bib0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/ars.2010.3874","article-title":"Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2\u03b1) impairs endothelial function in renovascular hypertensive rats","volume":"16","author":"Tian","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2018.01.001_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/ars.2011.4335","article-title":"Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension","volume":"18","author":"Mart\u00ednez-Revelles","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2018.01.001_bib0065","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/bph.13457","article-title":"Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension","volume":"173","author":"Avenda\u00f1o","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.HYP.0000084603.93510.28","article-title":"Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension","volume":"42","author":"Widlansky","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.001_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/HYPERTENSIONAHA.111.00995","article-title":"Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation","volume":"62","author":"Virdis","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.001_bib0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0092-8674(00)80571-1","article-title":"Generic signals and specific outcomes: signalling through Ca2+, calcineurin and NFAT","volume":"96","author":"Crabtree","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2018.01.001_bib0085","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1101\/gad.1102703","article-title":"Transcriptional regulation by calcium, calcineurin, and NFAT","volume":"17","author":"Hogan","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2018.01.001_bib0090","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/MCB.19.3.2032","article-title":"Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression","volume":"19","author":"Armesilla","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1050-1738(02)00212-8","article-title":"NFAT regulation in smooth muscle","volume":"13","author":"Hill-Eubanks","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2018.01.001_bib0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MOL.0b013e32830dd545","article-title":"Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys?","volume":"19","author":"Nilsson","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00007890-198702000-00023","article-title":"Evidence that renal prostaglandins and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity","volume":"43","author":"Coffman","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2018.01.001_bib0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1074-7613(00)80188-0","article-title":"Manipulating immune responses with immunosuppressive agents that target NFAT","volume":"12","author":"Kiani","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2018.01.001_bib0115","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/0929867043455576","article-title":"Inhibitors of the calcineurin\/NFAT pathway","volume":"8","author":"Mart\u00ednez-Mart\u00ednez","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0120","doi-asserted-by":"crossref","first-page":"29669","DOI":"10.1074\/jbc.M204519200","article-title":"Dephosphorylation of endothelial nitric oxide synthase by vascular endothelial growth factor: implications for the vascular responses to cyclosporin a","volume":"277","author":"Kou","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vph.2013.05.004","article-title":"Calcineurin-mediated dephosphorylation of eNOS at serine 116 affects eNOS enzymatic activity indirectly by facilitating c-Src binding and tyrosine 83 phosphorylation","volume":"59","author":"Ruan","year":"2013","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/mol.58.4.701","article-title":"Cyclosporin A selectively inhibits mitogen-induced cyclooxygenase-2 gene transcription in vascular smooth muscle cells","volume":"58","author":"Robida","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","article-title":"Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2","volume":"193","author":"Hern\u00e1ndez","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2018.01.001_bib0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/glia.20647","article-title":"Calcium\/calcineurin signaling in primary cortical astrocyte cultures: rcan1-4 and cyclooxygenase-2 as NFAT target genes","volume":"56","author":"Canellada","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2018.01.001_bib0145","doi-asserted-by":"crossref","first-page":"12733","DOI":"10.1128\/JVI.01065-10","article-title":"NFAT and CREB regulate kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)","volume":"84","author":"Sharma-Walia","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0150","doi-asserted-by":"crossref","first-page":"H1582","DOI":"10.1152\/ajpheart.00924.2013","article-title":"Pioglitazone reduces angiotensin II-induced COX-2 expression through the inhibition of ROS production and ET-1 transcription in vascular cells from SHR rats","volume":"306","author":"P\u00e9rez-Gir\u00f3n","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0155","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1074\/jbc.M113.514869","article-title":"Calcineurin A\u03b2 regulates NADPH oxidase (Nox) expression and activity via nuclear factor of activated T cells (NFAT) in response to high glucose","volume":"289","author":"Williams","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2174\/156800911795656001","article-title":"A cross-talk between NFAT and NF-\u03baB pathways is crucial for nickel-induced COX-2 expression in Beas-2 B cells","volume":"11","author":"Cai","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.phrs.2018.01.001_bib0165","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.275.12.8719","article-title":"A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling","volume":"275","author":"Rothermel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0170","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.14.13.1595","article-title":"A conserved family of calcineurin regulators","volume":"14","author":"Kingsbury","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2018.01.001_bib0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.0237225100","article-title":"Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy","volume":"100","author":"Vega","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.001_bib0180","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1084\/jem.20110503","article-title":"Regulator of calcineurin 1 mediates pathological vascular wall remodeling","volume":"208","author":"Esteban","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2018.01.001_bib0185","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/emmm.201302842","article-title":"A major role for RCAN1 in atherosclerosis progression","volume":"5","author":"M\u00e9ndez-Barbero","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2018.01.001_bib0190","doi-asserted-by":"crossref","first-page":"39051","DOI":"10.1074\/jbc.M604659200","article-title":"Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0195","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.4049\/jimmunol.1203196","article-title":"Regulator of calcineurin 1 suppresses inflammation during respiratory tract infections","volume":"190","author":"Junkins","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0200","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.1301271","article-title":"Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation","volume":"191","author":"Wu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0205","doi-asserted-by":"crossref","first-page":"e1929","DOI":"10.1038\/cddis.2015.260","article-title":"The RCAN1 inhibits NF-\u03baB and suppresses lymphoma growth in mice","volume":"6","author":"Liu","year":"2015","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.phrs.2018.01.001_bib0210","first-page":"2257","article-title":"The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice","volume":"119","author":"Minami","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.01.001_bib0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20081140","article-title":"Rcan1 negatively regulates Fc epsilonRI-mediated signalling and mast cell function","volume":"206","author":"Yang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2018.01.001_bib0220","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1073\/pnas.041614798","article-title":"Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo","volume":"98","author":"Rothermel","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.001_bib0225","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0230","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/ddm049","article-title":"RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration","volume":"16","author":"Porta","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2018.01.001_bib0235","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0008-6363(97)00079-5","article-title":"Spontaneous running increases aortic compliance in Wistar-Kyoto rats","volume":"35","author":"Kingwell","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2018.01.001_bib0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1113\/jphysiol.2003.046904","article-title":"Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling","volume":"552","author":"Briones","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0245","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.001_bib0250","doi-asserted-by":"crossref","first-page":"50537","DOI":"10.1074\/jbc.M406454200","article-title":"Vascular endothelial growth factor- and thrombin-induced termination factor Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis","volume":"279","author":"Minami","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.01.001_bib0255","doi-asserted-by":"crossref","first-page":"e11435","DOI":"10.1371\/journal.pone.0011435","article-title":"VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+\/calcineurin and protein kinase C-delta","volume":"5","author":"Holmes","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.001_bib0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.abb.2008.01.029","article-title":"Regulation of vascular function by RCAN1 (ADAPT78)","volume":"472","author":"Riper","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2018.01.001_bib0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-9-48","article-title":"Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia\/reperfusion injury","volume":"9","author":"Sobrado","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2018.01.001_bib0270","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2017.01323","article-title":"Endothelial regulator of calcineurin 1 (Rcan1) promotes barrier integrity and modulates histamine-induced barrier dysfunction in anaphylaxis","volume":"8","author":"Ballesteros-Martinez","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2018.01.001_bib0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2014.08.024","article-title":"The cyclooxygenase-2\/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?","volume":"354","author":"Huang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2018.01.001_bib0280","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.lfs.2013.08.014","article-title":"Differential role of cyclooxygenase-1 and \u22122 on renal vasoconstriction to \u03b1\u2081-adrenoceptor stimulation in normotensive and hypertensive rats","volume":"93","author":"D'Abril Ru\u00edz-Leyja","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2018.01.001_bib0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/HYPERTENSIONAHA.111.00995","article-title":"Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation","volume":"62","author":"Virdis","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.001_bib0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2006.10.015","article-title":"Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice","volume":"73","author":"Gitlin","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2018.01.001_bib0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCRESAHA.113.301033","article-title":"Cyclooxygenase-2-derived prostaglandin E\u2082 promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor","volume":"113","author":"Zhang","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2018.01.001_bib0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000255962","article-title":"Small artery remodeling: current concepts and questions","volume":"47","author":"van den Akker","year":"2010","journal-title":"J. Vasc. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:57:42Z","timestamp":1760911062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817312458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":60,"alternative-id":["S1043661817312458"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.001","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulator of calcineurin 1 modulates vascular contractility and stiffness through the upregulation of COX-2-derived prostanoids","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}